Cargando…
A System for Assessing Dual Action Modulators of Glycine Transporters and Glycine Receptors
Reduced inhibitory glycinergic neurotransmission is implicated in a number of neurological conditions such as neuropathic pain, schizophrenia, epilepsy and hyperekplexia. Restoring glycinergic signalling may be an effective method of treating these pathologies. Glycine transporters (GlyTs) control s...
Autores principales: | Sheipouri, Diba, Gallagher, Casey I., Shimmon, Susan, Rawling, Tristan, Vandenberg, Robert J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760315/ https://www.ncbi.nlm.nih.gov/pubmed/33266066 http://dx.doi.org/10.3390/biom10121618 |
Ejemplares similares
-
Photoswitchable ORG25543 Congener Enables Optical
Control of Glycine Transporter 2
por: Mostyn, Shannon N., et al.
Publicado: (2020) -
The allosteric inhibition of glycine transporter 2 by bioactive lipid analgesics is controlled by penetration into a deep lipid cavity
por: Wilson, Katie A., et al.
Publicado: (2021) -
Identification of an allosteric binding site on the human glycine transporter, GlyT2, for bioactive lipid analgesics
por: Mostyn, Shannon N, et al.
Publicado: (2019) -
Glycine Transporters and Receptors as Targets for Analgesics
por: Harvey, Robert J., et al.
Publicado: (2021) -
Glycine Transporter 2: Mechanism and Allosteric Modulation
por: Frangos, Zachary J., et al.
Publicado: (2021)